feed,title,long_url,short_url
Benzinga,Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market,https://benzinga.com/analyst-ratings/analyst-color/24/09/40802088/relay-therapeutics-faces-downgrade-over-efficacy-concerns-in-competitive-pi3k-inhib,https://da.gd/L9sDj
